You can buy or sell MGEN and other stocks, options, ETFs, and crypto commission-free!
Miragen Therapeutics, Inc. Common Stock, also called Miragen Therapeutics, is a clinical stage biopharmaceutical company, which engages in the development of proprietary RNA-targeted therapeutics. Read More Its product pipelines include MRG-106 that focuses on the treatment of blood cancer; and MRG-201 deals with the treatment of pathological fibrosis. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Boulder, CO.
52 Week High
52 Week Low
Expected Nov 6, After Hours